Cancer immunotherapy using a dendritic cell vaccine (DCV) is a supplementary cancer treatment method, created individually for each patient.
Individually for each patient developed stem cell preparation, which restore the functions of many types of damaged tissue.
T-cell preparation allow a doctor to stop the immune system’s response to the nerve-covering insulating layer of myelin.
Effectiveness of anti-cancer vaccination in treating metastasis in murine models
Lithuanians develop unique cancer immunotherapy products
+370 648 37 591
See us on Facebook
To play, press and hold the enter key. To stop, release the enter key.